1-Phenyl-2-propylaminopentane (PPAP), also known as α,N-dipropylphenethylamine (DPPEA) and by the developmental code name MK-306, is an experimental drug related to selegiline which acts as a catecholaminergic activity enhancer (CAE). PPAP is a CAE and enhances the nerve impulse propagation-mediated release of norepinephrine and dopamine.
1-Phenyl-2-propylaminopentane (PPAP), also known as α,N-dipropylphenethylamine (DPPEA) and by the developmental code name MK-306, is an experimental drug related to selegiline which acts as a catecholaminergic activity enhancer (CAE). PPAP is a CAE and enhances the nerve impulse propagation-mediated release of norepinephrine and dopamine.
Source: Wikipedia "Phenylpropylaminopentane" · CC BY-SA 4.0
Share this article: X · Bluesky